Laura Barrachina Porcar, DVM, PhD. Senior Scientis t, Manuel López Fello w Universidad de Zaragoza Zaragoza, Spain Cell and Gene Therapy Outreach and Education Resource Hub: Ignite discovery, inspire curiosity ...
ISCT Telegraft Member Spotlights is proud to feature Roberto Gramignoli, Ph.D . In this first feature of 2025. Dr. Gramignoli is an Associate Professor at the Karolinska Institute in Stockholm, Sweden, and the Head of the Department of Cell Therapies at the Gaslini Hospital in Genoa, Italy....
Miguel Forte, MD, PhD ISCT President mC4Tx Belgium We are just two months away from our ISCT Scientific Annual Meeting in New Orleans, under the theme of “ Driving Global Innovation Towards Patient Access ” . It will be the highlight moment of the year for all of us who are focused...
Joaquim Vives, PhD Contributing Editor, Telegraft Banc de Sang i Teixits Barcelona, Spain I earned my doctorate in 2002… that’s over 20 years ago, now (!) Throughout this time in research, I had the privilege of mentoring a diverse array of pre-doctoral...
Conrad Russell Y. Cruz MD PhD Senior Editor, Telegraft Children’s National Hospital, Washington DC The organizational psychologist Adam Grant writes that critical thinking requires us to: “(1) Be 10% more skeptical of people you agree with—and 10% more charitable to...
Janet Macpherson, Ph.D. Director SpanCyte Pty Ltd Sydney, NSW, Australia As we start 2025, many of our cell and gene therapy colleagues are heading to the first big events of the year. JPM Healthcare in San Francisco (13-16 Jan 2025) followed by Advanced Therapies...
Miguel Forte, MD, PhD ISCT President mC4Tx Belgium The year 2024 was another great year for patients with unmet medical needs as strong progress was made with cell and gene therapy products. We saw 10 new product approvals in between Europe, with EMA, and the US with the FDA....
Ashley Krull, Ph.D. Associate Director, Cell Therapy Manufacturing and Engineering James Cancer Hospital Cellular Therapy Laboratory Assistant Professor, Hematology The Ohio State University Columbus, Ohio, United States As 2024 draws to a close, the Editorial Board of the Telegraft is...
Adaeze Ekwe, PhD Junior Associate Editor ISCT ESP Leadership Development Program Cellular therapies have significantly evolved since inception as one of the most innovative and transformative approaches to treat diseases, offering new hope for patients with conditions previously deemed...
Miguel Forte, MD, PhD ISCT President mC4Tx Belgium Cell and gene therapy has come a long way, particularly since 2017 when the fantastic clinical outcomes and patient value that had been reported over the previous 5 year promised a great commercial opportunity with regulatory...